[FDMT] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[FDMT] 4D Molecular Therapeutics, Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 65.37%
YoY- 57.43%
Quarter Report
FDMT's Result
FDMT's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 5 28 -19 20,204 239 298 1,247 -97.48%
PBT -34,953 -32,401 -32,283 -10,256 -29,616 -28,682 -27,379 17.69%
Tax 0 -0 6,728 -3,876 -1,428 -1,424 -106 -
NP -34,953 -32,401 -32,283 -10,256 -29,616 -27,258 -27,273 18.00%
Tax Rate - - - - - - - -
Total Cost 34,958 32,429 32,264 30,460 29,855 27,556 28,520 14.54%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -699,060.00 -115,717.86 169,910.53 -50.76 -12,391.63 -9,146.98 -2,187.09 4591.28%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.63 -0.66 -0.83 -0.24 -0.77 -0.83 -0.84 -17.46%
EPS Diluted -0.63 -0.66 -0.83 -0.24 -0.77 -0.83 -0.84 -17.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.